These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. D'Souza A; Theis JD; Vrana JA; Dogan A Amyloid; 2014 Jun; 21(2):71-5. PubMed ID: 24446896 [TBL] [Abstract][Full Text] [Related]
8. The Pathology of Amyloidosis in Classification: A Review. Picken MM Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555 [TBL] [Abstract][Full Text] [Related]
9. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics. Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904 [TBL] [Abstract][Full Text] [Related]
10. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits. Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672 [TBL] [Abstract][Full Text] [Related]
12. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis. Dasari S; Amin MS; Kurtin PJ; Vrana JA; Theis JD; Grogg KL; Alexander MP; Nasr SH; Fervenza FC; Leung N; Sethi S Kidney Int; 2016 Sep; 90(3):658-64. PubMed ID: 27262366 [TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7. Chapman JR; Liu A; Yi SS; Hernandez E; Ritorto MS; Jungbluth AA; Pulitzer M; Dogan A Amyloid; 2021 Mar; 28(1):35-41. PubMed ID: 32867548 [TBL] [Abstract][Full Text] [Related]
14. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Leung N; Nasr SH; Sethi S Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045 [TBL] [Abstract][Full Text] [Related]
15. Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesis. Brambilla F; Lavatelli F; Valentini V; Di Silvestre D; Obici L; Mauri P; Merlini G Amyloid; 2012 Jun; 19 Suppl 1():11-3. PubMed ID: 22551153 [TBL] [Abstract][Full Text] [Related]
16. Proteomic typing of amyloid deposits in systemic amyloidoses. Lavatelli F; Vrana JA Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761 [TBL] [Abstract][Full Text] [Related]
17. The amyloid proteome: a systematic review and proposal of a protein classification system. Gottwald J; Röcken C Crit Rev Biochem Mol Biol; 2021 Oct; 56(5):526-542. PubMed ID: 34311636 [TBL] [Abstract][Full Text] [Related]
18. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing. Lavatelli F; Merlini G Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069 [TBL] [Abstract][Full Text] [Related]
19. MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits. Winter M; Tholey A; Krüger S; Schmidt H; Röcken C J Histochem Cytochem; 2015 Oct; 63(10):772-9. PubMed ID: 26101327 [TBL] [Abstract][Full Text] [Related]
20. [Amyloid Registry Kiel : An interim balance]. Röcken C Pathologe; 2018 Dec; 39(Suppl 2):301-305. PubMed ID: 30302563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]